Recent News

• 03.26.2026 - Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
• 03.12.2026 - Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026
• 01.21.2026 - Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®
• 12.09.2025 - Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection
• 11.20.2025 - Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree
• 11.13.2025 - Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Recent Filings

• 02.24.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2026 - 4 Statement of changes in beneficial ownership of securities